Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Oppenheim

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Biology : CB|February 7, 2001
Gamma(delta) T cells: non-classical ligands for non-classical cellsC R Steele, D E Oppenheim, A C Hayday
Science (New York, N.Y.)|September 22, 2001
Regulation of cutaneous malignancy by gammadelta T cellsM Girardi, D E Oppenheim, C R Steele, et al.
British Journal of Cancer|February 6, 2014
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapyD E Oppenheim, R Spreafico, A Etuk, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Biology : CB|February 7, 2001
Gamma(delta) T cells: non-classical ligands for non-classical cellsC R Steele, D E Oppenheim, A C Hayday
Science (New York, N.Y.)|September 22, 2001
Regulation of cutaneous malignancy by gammadelta T cellsM Girardi, D E Oppenheim, C R Steele, et al.
British Journal of Cancer|February 6, 2014
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapyD E Oppenheim, R Spreafico, A Etuk, et al.
Pageof 1